Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,103 | 258 | 87.7% |
| Consulting Fee | $1,125 | 1 | 10.8% |
| Education | $155.32 | 5 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,352 | 80 | $0 (2024) |
| Novo Nordisk Inc | $2,288 | 43 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $621.76 | 16 | $0 (2022) |
| Amgen Inc. | $466.24 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $464.68 | 14 | $0 (2024) |
| PFIZER INC. | $460.26 | 16 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $452.97 | 10 | $0 (2023) |
| Lilly USA, LLC | $403.04 | 16 | $0 (2023) |
| ABBVIE INC. | $383.04 | 12 | $0 (2022) |
| Astellas Pharma US Inc | $149.01 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $434.73 | 10 | AstraZeneca Pharmaceuticals LP ($149.86) |
| 2023 | $2,245 | 28 | Novo Nordisk Inc ($1,180) |
| 2022 | $1,966 | 44 | AstraZeneca Pharmaceuticals LP ($658.32) |
| 2021 | $1,757 | 48 | AstraZeneca Pharmaceuticals LP ($942.27) |
| 2020 | $362.49 | 17 | AstraZeneca Pharmaceuticals LP ($195.13) |
| 2019 | $1,196 | 35 | AstraZeneca Pharmaceuticals LP ($249.11) |
| 2018 | $1,708 | 48 | AstraZeneca Pharmaceuticals LP ($590.77) |
| 2017 | $713.76 | 34 | AstraZeneca Pharmaceuticals LP ($155.11) |
All Payment Transactions
264 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Respiratory | ||||||
| 03/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $16.65 | General |
| Category: Allergy/Immunology | ||||||
| 02/27/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/26/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $122.07 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Biological | ||||||
| 01/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Respiratory | ||||||
| 01/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Cardio-renal | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $102.80 | General |
| Category: Respiratory | ||||||
| 11/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: Cardiology | ||||||
| 10/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: Inflammation | ||||||
| 09/11/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Respiratory | ||||||
| 08/22/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neuromodulation | ||||||
| 08/17/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 08/08/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Inflammation | ||||||
| 07/27/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Oncology | ||||||
| 07/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: Biological | ||||||
| 07/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Respiratory | ||||||
| 06/14/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $109.90 | General |
| Category: Respiratory | ||||||
| 04/18/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $125.08 | General |
| 04/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 194 | 233 | $31,890 | $14,345 |
| 2022 | 6 | 340 | 572 | $55,789 | $29,472 |
| 2021 | 19 | 1,891 | 2,159 | $164,733 | $87,257 |
| 2020 | 12 | 570 | 918 | $94,639 | $47,547 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $8,400 | $5,394 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 86 | $14,280 | $5,328 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 27 | 29 | $6,900 | $2,749 | 39.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 36 | 44 | $590.00 | $369.60 | 62.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 18 | 18 | $840.00 | $318.60 | 37.9% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $880.00 | $185.96 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 157 | 353 | $42,360 | $22,052 | 52.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 42 | 42 | $6,300 | $4,973 | 78.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 36 | 53 | $4,770 | $1,960 | 41.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 74 | 93 | $930.00 | $273.69 | 29.4% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 11 | 11 | $629.02 | $123.20 | 19.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 20 | $800.00 | $90.19 | 11.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 192 | 376 | $45,120 | $24,542 | 54.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 70 | 70 | $10,500 | $9,045 | 86.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 93 | $13,950 | $8,182 | 58.6% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 198 | 198 | $15,840 | $8,069 | 50.9% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 194 | 194 | $15,520 | $7,336 | 47.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 153 | 153 | $12,240 | $6,235 | 50.9% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 175 | 176 | $14,080 | $5,935 | 42.2% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 141 | 141 | $11,280 | $5,746 | 50.9% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 111 | 111 | $8,880 | $4,523 | 50.9% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 79 | 79 | $6,320 | $3,219 | 50.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,990 | $1,083 | 36.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 21 | 23 | $2,070 | $981.42 | 47.4% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 23 | 27 | $1,755 | $711.18 | 40.5% |
About Dr. Muhammad Khan, MD
Dr. Muhammad Khan, MD is a Internal Medicine healthcare provider based in Saint Cloud, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588613376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Khan, MD has received a total of $10,383 in payments from pharmaceutical and medical device companies, with $434.73 received in 2024. These payments were reported across 264 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,103).
As a Medicare-enrolled provider, Khan has provided services to 2,995 Medicare beneficiaries, totaling 3,882 services with total Medicare billing of $178,620. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Saint Cloud, FL
- Active Since 05/09/2006
- Last Updated 12/01/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588613376
Products in Payments
- FARXIGA (Drug) $1,674
- BREZTRI (Drug) $839.11
- Ozempic (Drug) $625.30
- XARELTO (Drug) $403.15
- Rybelsus (Drug) $338.28
- BEVESPI AEROSPHERE (Drug) $299.57
- ELIQUIS (Drug) $283.73
- BYDUREON (Drug) $229.03
- INVOKANA (Drug) $218.61
- TRULICITY (Drug) $207.35
- JARDIANCE (Drug) $181.28
- RYBELSUS (Drug) $162.19
- UBRELVY (Drug) $158.47
- AIRSUPRA (Drug) $149.86
- MOUNJARO (Drug) $146.19
- Cologuard Collection Kit (Device) $143.58
- Repatha (Biological) $142.94
- Prolia (Biological) $141.61
- Aimovig (Biological) $138.58
- CHANTIX (Drug) $124.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Saint Cloud
Thom Dahle, Md, MD
Internal Medicine — Payments: $1.1M
Jamie Pelzel, Md, MD
Internal Medicine — Payments: $66,776
Dr. Mohsan Chaudhry, Md, MD
Internal Medicine — Payments: $34,376
Dr. Hardik Doshi, M.d, M.D
Internal Medicine — Payments: $26,129
Dr. Abdul Lodhi, M.d, M.D
Internal Medicine — Payments: $7,145
Kwame Ntim, Md, MD
Internal Medicine — Payments: $6,447